Literature DB >> 24146255

The effect of an APOE polymorphism on cognitive function depends on age.

Min-Ho Shin1, Sun-Seog Kweon, Jin-Su Choi, Young-Hoon Lee, Hae-Sung Nam, Kyeong-Soo Park, Hee N Kim, Hye-Rim Song, Byeong C Kim, Seong-Min Choi, Sun-Young Oh, Seul-Ki Jeong.   

Abstract

It remains controversial whether APOE E4 polymorphism is related to cognitive function in general population. We aimed to evaluate an association between the APOE E4 genotype and cognitive function, and whether this association may differ by age. Cognitive function was assessed using the Korean version of modified Mini-Mental State Examination (K-mMMSE) in 10,371 Koreans aged 45-74 years in Namwon City. According to the APOE E4 status, all participants were classified as non-carriers, heterozygotes, or homozygotes. Multiple linear and logistic regression models were used to evaluate the association between APOE genotypes and cognition. The frequency of APOE genotypes in the study population was 0.4, 10.1, 1.1, 72.9, 14.7 and 0.8 % for E2E2, E2E3, E2E4, E3E3, E3E4, and E4E4, respectively. Compared to the APOE E4 non-carriers, the heterozygotes and homozygotes showed 1.3 and 7.3 % lower K-mMMSE scores at 65-74 years and 0.8 and 4.6 % higher scores at 45-55 years, respectively. Educational attainment modified the effect of APOE E4 on cognitive function in the 45-54 age group (p for interaction =0.003), showing that the E4 carriers with no-formal education showed significantly higher cognitive function than those with formal education. The present study demonstrates that the effect of APOE E4 on cognitive function depends on age and education.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24146255     DOI: 10.1007/s00415-013-7157-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures.

Authors:  J M Rusted; S L Evans; S L King; N Dowell; N Tabet; P S Tofts
Journal:  Neuroimage       Date:  2012-10-11       Impact factor: 6.556

2.  Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.

Authors:  M Morishima-Kawashima; N Oshima; H Ogata; H Yamaguchi; M Yoshimura; S Sugihara; Y Ihara
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 3.  Antagonistic pleiotropy, mutation accumulation, and human genetic disease.

Authors:  R L Albin
Journal:  Genetica       Date:  1993       Impact factor: 1.082

4.  Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Authors:  Trey Sunderland; Gary Linker; Nadeem Mirza; Karen T Putnam; David L Friedman; Lida H Kimmel; Judy Bergeson; Guy J Manetti; Matthew Zimmermann; Brian Tang; John J Bartko; Robert M Cohen
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

5.  Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.

Authors:  Robert M Koffie; Tadafumi Hashimoto; Hwan-Ching Tai; Kevin R Kay; Alberto Serrano-Pozo; Daniel Joyner; Steven Hou; Katherine J Kopeikina; Matthew P Frosch; Virginia M Lee; David M Holtzman; Bradley T Hyman; Tara L Spires-Jones
Journal:  Brain       Date:  2012-05-26       Impact factor: 13.501

6.  Apolipoprotein E and cognitive performance: a meta-analysis.

Authors:  Brent J Small; Christopher B Rosnick; Laura Fratiglioni; Lars Bäckman
Journal:  Psychol Aging       Date:  2004-12

7.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

8.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

Authors:  T Wisniewski; E M Castaño; A Golabek; T Vogel; B Frangione
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  The effect of apolipoprotein E polymorphism on lipid levels in Korean adults.

Authors:  Min-Ho Shin; Hee-Nam Kim; Lian-Hua Cui; Sun-Seog Kweon; Kyeong-Soo Park; Heon Heo; Hae-Sung Nam; Seul-Ki Jeong; Eun-Kyung Chung; Jin-Su Choi
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

View more
  6 in total

1.  A disease modification effect of APOE E4 on the association between urinary albumin excretion and cognition in Korean adults.

Authors:  Min-Ho Shin; Sun-Seog Kweon; Jin-Su Choi; Young-Hoon Lee; Hae-Sung Nam; Kyeong-Soo Park; Hee Nam Kim; Sun-Young Oh; Seul-Ki Jeong
Journal:  Dis Markers       Date:  2014-10-30       Impact factor: 3.434

2.  APOE ε4 allele accelerates age-related multi-cognitive decline and white matter damage in non-demented elderly.

Authors:  Jinping Sun; Zhibao Zhu; Kewei Chen; Dongfeng Wei; Xin Li; He Li; Junying Zhang; Xiaochun Chen; Yaojing Chen; Zhanjun Zhang
Journal:  Aging (Albany NY)       Date:  2020-06-22       Impact factor: 5.682

3.  Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.

Authors:  Xurui Jin; Wanying He; Yan Zhang; Enying Gong; Zhangming Niu; John Ji; Yaxi Li; Yi Zeng; Lijing L Yan
Journal:  PLoS Med       Date:  2021-06-01       Impact factor: 11.613

4.  Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme.

Authors:  Tamuno Alfred; Yoav Ben-Shlomo; Rachel Cooper; Rebecca Hardy; Cyrus Cooper; Ian J Deary; Jane Elliott; David Gunnell; Sarah E Harris; Mika Kivimaki; Meena Kumari; Richard M Martin; Chris Power; Avan Aihie Sayer; John M Starr; Diana Kuh; Ian N M Day
Journal:  Age (Dordr)       Date:  2014-07-30

5.  Effect of apolipoprotein E polymorphism on cognition and brain in the Cambridge Centre for Ageing and Neuroscience cohort.

Authors:  Richard N Henson; Sana Suri; Ethan Knights; James B Rowe; Rogier A Kievit; Donald M Lyall; Dennis Chan; Else Eising; Simon E Fisher
Journal:  Brain Neurosci Adv       Date:  2020-10-07

6.  The Neurocognitive Study for the Aging: Longitudinal Analysis on the Contribution of Sex, Age, Education and APOE ɛ4 on Cognitive Performance.

Authors:  Andreas Chadjikyprianou; Marilena Hadjivassiliou; Savvas Papacostas; Fofi Constantinidou
Journal:  Front Genet       Date:  2021-07-13       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.